FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Om Ganda

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Geographic Areas

United States

Procedures

Activities & Behaviors

Smoking Cessation

Co-author Network

Publications

TOP 3
Elizabeth A Beverly; A Enrique Caballero; Shane Fitzgerald; Om P Ganda; Lilya Sitnikov; Katie Weinger
Do older adults aged 60-75 years benefit from diabetes behavioral interventions?
Paul S Jellinger; Adi E Mehta; Helena W Rodbard; John A Seibel; Mark D Shepherd; Donald A Smith; Om P Ganda; Yehuda Handelsman
American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis.
Paul S Jellinger; Adi E Mehta; Helena W Rodbard; John A Seibel; Mark D Shepherd; Donald A Smith; Om P Ganda; Yehuda Handelsman
American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis: executive summary.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Om Ganda (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Elizabeth A Beverly; A Enrique Caballero; Shane Fitzgerald; Om P Ganda; Lilya Sitnikov; Katie Weinger
Do older adults aged 60-75 years benefit from diabetes behavioral interventions?
Diabetes care 2013;36(6):1501-6.
2012: Paul S Jellinger; Adi E Mehta; Helena W Rodbard; John A Seibel; Mark D Shepherd; Donald A Smith; Om P Ganda; Yehuda Handelsman
American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2012;18 Suppl 1():1-78.
2012: Paul S Jellinger; Adi E Mehta; Helena W Rodbard; John A Seibel; Mark D Shepherd; Donald A Smith; Om P Ganda; Yehuda Handelsman
American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis: executive summary.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2012;18(2):269-93.
2011: Bijan Roshan; Edmund Ward; Bela F Asztalos; Ranil Desilva; Om P Ganda; Rose B Ganim; Sarah D Haessler; Eliana Y Polisecki; Ernst J Schaefer
Homozygous lecithin:cholesterol acyltransferase (LCAT) deficiency due to a new loss of function mutation and review of the literature.
Journal of clinical lipidology 2011;5(6):493-9.
2010: Om P Ganda
The role of bile acid sequestrants in the management of type 2 diabetes mellitus.
Metabolic syndrome and related disorders 2010;8 Suppl 1():S15-21.
2010: Om P Ganda; Vivian A Fonseca
Salt sensitivity, insulin resistance, and public health in India.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2010;16(6):940-4.
2009: Om P Ganda
Refining lipoprotein assessment in diabetes: apolipoprotein B makes sense.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2009;15(4):370-6.
2008: Om P Ganda
A targeted, multifactorial intervention reduced mortality in patients with type 2 diabetes and microalbuminuria.
ACP journal club 2008;149(2):4.
2007: Om P Ganda
Review: meglitinide analogues reduce glucose levels in type 2 diabetes, but morbidity and mortality effects are unknown.
ACP journal club 2007;147(3):65.
2007: Anoop Misra; Om P Ganda
Migration and its impact on adiposity and type 2 diabetes.
Nutrition (Burbank, Los Angeles County, Calif.) 2007;23(9):696-708.
2006: Om P Ganda
Ask the doctor. I have been taking niacin for several years, and it has helped keep my good and bad cholesterol in their healthy ranges. Now I have been diagnosed with diabetes, and my doctor forbids me from taking niacin any more. What's the reasoning behind this?
Harvard heart letter : from Harvard Medical School 2006;16(12):8.
2006: Arlene Smaldone; Om P Ganda; Sheila McMurrich; Keri Hannagan; Susan Lin; A Enrique Caballero; Katie Weinger
Should group education classes be separated by type of diabetes?
Diabetes care 2006;29(7):1656-8.
2005: Om P Ganda
The role of lipid management in diabetes.
Cardiology clinics 2005;23(2):153-64, vi.
2003: Om P Ganda
Insulin resistance syndrome: implications for the Asian American population.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2003;9 Suppl 2():31-4.
2003: Daniel Einhorn; Gerald M Reaven; Rhoda H Cobin; Earl Ford; Om P Ganda; Yehuda Handelsman; richard hellman; Paul S Jellinger; David Kendall; Ronald M Krauss; Naomi D Neufeld; Steven M Petak; Helena W Rodbard; John A Seibel; Donald A Smith; Peter W F Wilson
American College of Endocrinology position statement on the insulin resistance syndrome.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2003;9(3):237-52.
2002: Scott M Grundy; Gloria Lena Vega; Mark E McGovern; Brian R Tulloch; David M Kendall; David Fitz-Patrick; Om P Ganda; Robert S Rosenson; John B Buse; David D Robertson; John P Sheehan
Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial.
Archives of internal medicine 2002;162(14):1568-76.
2002: Om P Ganda
Review: interventions that lower cholesterol levels or blood pressure in diabetic patients prevent cardiovascular disease.
ACP journal club 2002;137(1):3.